Search clinical trials for: (fimasartan and linagliptin) x 7days

Total 2561 results

Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers

Essential Hypertension
Boryung Pharmaceutical Co., Ltd

Completed

A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.

Hypertension, Hyperlipidemia

Korea, Republic of
Boehringer Ingelheim
Eli Lilly and Company

Completed

Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy

Diabetes Mellitus, Type 2

United States
Boehringer Ingelheim

Completed

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Czech Republic, Finland, Greece, India, Israel, Mexico, New Zealand, Russian Federation, Sweden
Biogen

Completed

Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke (ACTION)

Acute Ischemic Stroke

Spain, United States, Germany
Ohio State University Comprehensive Cancer Center

Completed

Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer Survivors

Prostate Carcinoma

United States
EMS

Not yet recruiting

Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus

Type 2 Diabetes Mellitus
Boehringer Ingelheim
Eli Lilly and Company

Completed

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Japan
Shihezi University

Completed

the New Biomarker of the Knee Osteoarthritis Knee Osteoarthritis Occurrence and Progression

Knee Osteoarthritis
Fayoum University
Boehringer Ingelheim

Completed

Contrast Nephropathy in Type 2 Diabetes (VCG4)

Diabetes | Microalbuminuria | Kidney Function Affection Upon Exposure to Radiocontrast

Egypt
Emory University
Boston Medical Center; Rush University; University of Denver

Completed

Linagliptin Inpatient Trial

Type 2 Diabetes

United States
University of Oxford
National Institute of Allergy and Infectious Diseases (NIAID); Wellcome Trust

Completed

A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo

Ebola | Ebola Zaire

United Kingdom
Yonsei University

Completed

Feasibility of AI-based Heart Function Prediction Model Using CXR (AI-CXR)

Chest X-ray for Clinical Evaluation

Korea, Republic of
Asian Institute of Gastroenterology, India

Completed

Endoscopic Full Thickness Plication (GERD-X) for the Treatment of PPI Dependent GERD:

Gastro Esophageal Reflux Disease

India
University Hospital Birmingham

Recruiting

The Effects of Growth Hormone Treatment Discontinuation in Adults on Metabolic Profile, Body Composition and Quality Of Life (GAMBOL Study) (GAMBOL)

Adult Growth Hormone Deficiency

United Kingdom
Sichuan University
Betta Pharmaceuticals Co., Ltd.

Not yet recruiting

A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer | ALK Fusion Protein Expression | Adjuvant Therapy
Immunolight, LLC

Recruiting

X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma

Advanced Solid Tumor Cancer

United States
University of New Mexico

Terminated

Nutrition Status, BMD, and SSRIs

BMD
Duke University
Smith & Nephew, Inc.

Completed

Transphyseal Vs. Physeal Sparing ACL Reconstruction in Skeletally Immature Patients: Risk of Subsequent Lower Extremity Growth Deformity

ACL Reconstruction

United States
Professor Adrian Covic
Falcon Trading Iasi; Romanian Academy of Medical Sciences

Unknown

Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays (AI-COVID-Xr)

COVID-19 | Pneumonia, Viral | Pneumonia, Ventilator-Associated | Flu Symptom | Flu Like Illness | Influenza With Pneumonia | Pneumonia, Interstitial | Pneumonia Atypical

Italy, Romania, United Kingdom
Andrea Kew

Completed

Safety and Efficacy of Iron Reduction by Phlebotomy

Iron Overload

Canada
Korea University Anam Hospital

Completed

The Pharmacokinetics, Safety and Tolerability of IN-C009 in Healthy Subjects

Diabetes Mellitus

Korea, Republic of
Indiana University

Completed

Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome (IBS)

IBS

United States
Boehringer Ingelheim

Completed

BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes

Diabetes Mellitus, Type 2

Argentina, Belgium, Canada, China, Germany, Korea, Republic of, Philippines, Russian Federation, Taiwan, Turkey, United Kingdom
Boehringer Ingelheim

Completed

Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control

Diabetes Mellitus, Type 2

Croatia, India, Israel, Italy, Malaysia, Netherlands, Poland, Romania, Slovakia, Thailand, Ukraine
CNGE Conseil

Completed

Description of Pneumococcal Pneumonia (PneumoCAP)

Community-acquired Pneumonia

France
Boehringer Ingelheim
Eli Lilly and Company

Completed

Linagliptin Add-on to Insulin Background Therapy

Diabetes Mellitus, Type 2

China
Boehringer Ingelheim
Eli Lilly and Company

Completed

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/1000mg) Extended Release in Healthy Subjects.

Healthy

Germany
LG Life Sciences

Completed

A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study) (GUARD)

Type 2 DM Patients With Moderate or Severe Renal Impairment

Korea, Republic of
Ministry of Public Health, Argentina
Aix Marseille Université; Instituto de Biología y Medicina Experimental, IBYME...

Unknown

Effect of Linagliptin on TRL Metabolism

Type 2 Diabetes

Argentina
Boehringer Ingelheim

Completed

Bioequivalence of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy Volunteers

Healthy
Boryung Pharmaceutical Co., Ltd
Seoul National University Hospital

Completed

A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

Hypertension

Korea, Republic of
Khoo Teck Puat Hospital

Completed

Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment

Type II Diabetes in Subjects BMI 27 to 32

Singapore
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients

Type 2 Diabetes Mellitus

China
Mayo Clinic

Recruiting

Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial

AL Amyloidosis

United States
Human Genome Sciences Inc.
GlaxoSmithKline

Completed

Study of Belimumab Administered Subcutaneously to Healthy Subjects

Healthy

United States
Rabin Medical Center

Terminated

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19

Glucose Metabolism Disorders | Respiratory Tract Diseases | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | COVID 19 | Coronavirus | Metabolic Disease | Severe Acute Respiratory Syndrome Coronavirus 2 | Sars-CoV2 | Hormones | Hypoglycemic Agents | Incretins | Dipeptidyl-Peptidase IV Inhibitors and other conditions

Israel
Vendsyssel Hospital
Charite University, Berlin, Germany; Umeå University; Leiden University Medical... and other collaborators

Completed

Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study

Schistosomiasis

Madagascar
University of the Balearic Islands

Not yet recruiting

Efficacy of Physical Exercise on Glucose Control in People With Prediabetes (GLYCEX) - Phase II (GLYCEX)

PreDiabetes
Pfizer

Completed

Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)

Rheumatoid Arthritis

United States, Australia, Canada, Israel, Mexico, Colombia, Germany, Russian Federation, South Africa, United Kingdom
Shanghai 10th People's Hospital

Completed

Non-alcoholic Fatty Liver Disease and Its Treatment

NAFLD
University of Wisconsin, Madison
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Resveratrol With or Without Piperine to Enhance Plasma Levels of Resveratrol

Focus of the Study: Normal Volunteers

United States
PATH

Completed

Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults

Shigellosis

United States
Dong Wha Pharmaceutical Co. Ltd.

Completed

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers

Healthy Subjects

Korea, Republic of
University Hospital Inselspital, Berne
Fresenius Kabi

Completed

The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies (Glutaminprojec)

Malnourishment | Gastrointestinal Tumors

Switzerland
Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Tablets Under Fed Conditions

Healthy

Canada
Merck Sharp & Dohme LLC

Completed

Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)

Type 2 Diabetes
Essential Medical, Inc.

Completed

X-Seal EU Post-Market Clinical Follow-Up Protocol

Femoral Arteriotomy Closure

Germany
Bausch & Lomb Incorporated

Completed

Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT (JUPITER)

Ocular Hypertension | Glaucoma

United States
Ungku Shahrin Medical Aesthetic Research & Innovation...

Completed

Safety and Efficacy of Facial Cleanser

Healthy

Malaysia

Search clinical trials for: (fimasartan and linagliptin) x 7days

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations